1. Home
  2. AUBN vs PMVP Comparison

AUBN vs PMVP Comparison

Compare AUBN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auburn National Bancorporation Inc.

AUBN

Auburn National Bancorporation Inc.

N/A

Current Price

$25.45

Market Cap

88.8M

Sector

Finance

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.16

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUBN
PMVP
Founded
1907
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
76.8M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AUBN
PMVP
Price
$25.45
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4K
296.3K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
4.61%
N/A
EPS Growth
13.66
N/A
EPS
0.63
N/A
Revenue
$619,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.11
N/A
Revenue Growth
0.81
N/A
52 Week Low
$21.60
$0.96
52 Week High
$29.00
$1.88

Technical Indicators

Market Signals
Indicator
AUBN
PMVP
Relative Strength Index (RSI) 71.26 48.32
Support Level $24.00 $1.13
Resistance Level $27.76 $1.26
Average True Range (ATR) 0.40 0.07
MACD 0.14 0.02
Stochastic Oscillator 98.13 55.32

Price Performance

Historical Comparison
AUBN
PMVP

About AUBN Auburn National Bancorporation Inc.

Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: